Drugs / Jinhua Qinggan (JHQG) Granules

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04723524 Sep 2020 → Aug 2021 COVID-19 University of Karachi Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Jinhua Qinggan (JHQG) Granules ClinicalTrials.gov intervention name — accepted as the source's own label NCT04723524 ↗
Known as JHQG “The efficacy of Jinhua Qinggan granules (JHQG) in COVID-19 patients with mild symptoms has yet to be clearly defined.” PMID 35979216 ↗ Aug 2022
Known as Jinhua Qinggan granules “The efficacy of Jinhua Qinggan granules (JHQG) in COVID-19 patients with mild symptoms has yet to be clearly defined.” PMID 35979216 ↗ Aug 2022
Modality Traditional medicine (herbal / TCM) “Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine” NCT04723524 ↗
Route Oral “Participants were randomly assigned to receive 5 g/sacket of JHQG or placebo granules orally thrice daily for 10 days.” PMID 35979216 ↗ Aug 2022